News
LFMD
4.540
+6.07%
0.260
Weekly Report: what happened at LFMD last week (0504-0508)?
Weekly Report · 3d ago
LifeMD Earnings Call: Growth Surges, Profits Deferred
TipRanks · 6d ago
LifeMD (LFMD) Receives a Buy from Lake Street
TipRanks · 6d ago
LifeMD (LFMD) Gets a Buy from BTIG
TipRanks · 05/07 11:38
Lifemd reaffirms 2026 guidance of $220M-$230M revenue and $12M-$17M adjusted EBITDA as it targets $250M+ run-rate revenue by Q4
Seeking Alpha · 05/07 03:04
LifeMD reports Q1 EPS (20c), consensus (12c)
TipRanks · 05/07 00:47
LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M
TipRanks · 05/07 00:46
LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M
TipRanks · 05/07 00:45
LifeMD Posts Q1 Results, Reaffirms 2026 Profitability Outlook
TipRanks · 05/06 23:22
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 05/06 21:03
LifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Reuters · 05/06 20:45
LifeMD Q1 FY26 adjusted EBITDA loss widens to $4.5 million; revenue falls 1% to $50.2 million
PUBT · 05/06 20:25
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), AC Immune SA (ACIU) and Gilead Sciences (GILD)
TipRanks · 05/04 11:30
Weekly Report: what happened at LFMD last week (0427-0501)?
Weekly Report · 05/04 09:22
LifeMD to report first-quarter results after market close, host conference call
PUBT · 04/27 12:03
Weekly Report: what happened at LFMD last week (0420-0424)?
Weekly Report · 04/27 09:23
LifeMD management to meet with BTIG
TipRanks · 04/24 17:05
Amazon GLP-1 Program Pressures Hims & Hers Stock
Benzinga · 04/21 17:22
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
NASDAQ · 04/21 12:00
LifeMD Shares Rise After Offering Lilly's GLP-1 Obesity Pill
Dow Jones · 04/20 16:15
More
Webull provides a variety of real-time LFMD stock news. You can receive the latest news about Lifemd Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFMD
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.